pharmaphorum

AUGUST 19, 2022

It will provide a low-cost online consultation and prescription medicine service to patients, starting with the two oral COVID-19 antivirals – Pfizer’s Paxlovid (nirmatrelvir/ritonavir) and Merck & Co’s Lagevrio (molnupiravir) – which are authorised for at-home use by the FDA.

Prescription 86

Prescription Healthcare Healthcare Healthcare Provider 86

Rep-Lite

MAY 10, 2024

The rise of telehealth is altering the way healthcare is delivered, and medical sales are following suit. The proliferation of telehealth solutions has led to a significant rise in virtual sales interactions and consultations, with healthcare providers and decision-makers embracing remote communication channels.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

PM360

NOVEMBER 21, 2022

governments have been in lawsuits with the pharmacies for years, claiming they filled opioid prescriptions that should have been flagged, contributing to the drug industry’s role in an overdose crisis that has been linked to more than 500,000 deaths in the U.S. billion to governments and $155 million to tribes over 15 years.

Government 52

Government Prescription FDA Patients 52

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 77

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 77

Clarify Health

OCTOBER 26, 2021

Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. To advance equity in clinical research, the U.S. In fact, 73% were White, 14% were Asian, 6% were Hispanic, and 5% were African American.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

Clarify Health

APRIL 15, 2021

Addressing the challenges of underdiagnoses when launching a rare disease drug Within the past decades, the government has pushed regulatory and financial incentives to encourage the development of rare disease drugs. And 95% of rare diseases do not have any FDA-approved therapeutic. Clinically, NASH is difficult to diagnose.

FDA 52

FDA Patients Healthcare Provider Government 52

Nixon Gwilt Law

NOVEMBER 3, 2022

This requires that both the manufacturer and telemedicine company comply with applicable FDA labeling requirements, which can be complex. In healthcare, however, the ability to generate additional revenue through self-referral can result in the overutilization of services, or referral of patients for unnecessary services.

Physicians 59

Physicians Healthcare Provider Healthcare Healthcare 59

Salesforce

JUNE 3, 2021

But incentives like free lottery tickets or vouchers for free tickets to sporting events along with the FDA recently authorizing the Pfizer-BioNTech vaccine for emergency use in those aged 12-15 are propelling the continued effort to vaccinate as many people as possible.

Healthcare 52

Healthcare Healthcare Management Healthcare Provider 52

Pharmaceutical Technology

NOVEMBER 15, 2022

Paxlovid first hit the shelves in the US last December after the Food and Drug Administration (FDA) granted the treatment an emergency use authorisation (EUA). Thus, governments are simultaneously tackling issues surrounding Paxlovid rebound and aiming to increase booster uptake in their continued Covid-19 prevention efforts.

Food and Drug Administration 64

Food and Drug Administration Government Distribution FDA 64

PM360

JUNE 11, 2022

When asked how pharma companies could earn more trust from patients, lower drug prices and other financially supported access to treatment ranked as the top things patients would want to see along with more educational resources and support of government policies to protect patients’ rights.

Patients 59

Patients Pharma Education Media 59

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. The vaccine, which recently received an FDA Breakthrough Therapy designation, had an efficacy of 83.7% per 100,000.

Pharma 64

Pharma Pharmaceutical FDA Healthcare Provider 64

Cadensee

JULY 20, 2021

So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology. Taking the longer but more profitable road, I would say, at the end of doing an FDA, doing something that has meaning, getting a claim that that makes a dent is much better.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 6, 2023

Last year, Novartis began with a win in January, as the US Court of Appeals affirmed the validity of Gilenya’s patent, allowing the company to sue a competitor generics company for filing for FDA approval for its Gilenya generic. Gilenya is an oral medication for multiple sclerosis. Novartis vs Greece. Fighting Entresto generics.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

MARCH 16, 2023

Dr Sean Cahill, PhD, the associate editor of the global, peer-reviewed journal LGBT Health, says “for most young people, healthcare provided doesn’t even go beyond that [social affirmation of gender identity], but a lot of people… are misrepresenting what gender affirming care looks like in this country”.

Ethics 144

Ethics Prescription Safety Healthcare 144

pharmaphorum

AUGUST 31, 2022

In a blog post , assistant secretary for preparedness and response Dawn O’Connell writes that the federal government has “always intended to transition this work to the commercial market and have been planning for that transition.” The post COVID-19 money could run out in January, says US government appeared first on.

Government 87

Government Insurance Distribution Healthcare Provider 87